BENGALURU (Reuters): The Indian government said on Thursday it was providing a full exemption from basic customs duty for rare disease therapies and Merck & Co Inc’s (MRK.N) cancer therapy Keytruda when such medicines were imported for personal use.
The government said in a statement that while some drugs such as treatments for spinal muscular atrophy or Duchenne muscular dystrophy are already exempted from customs duty, it had received many requests for relief from import tax for other rare disease drugs.
For a child weighing 10 kilograms, the annual cost of treatment for rare diseases may vary from 1 million rupees ($12,172) to 10 million rupees per year, according to the Ministry of Finance statement.
“This exemption will result in substantial cost savings and provide much needed relief to the patients,” the ministry added.
Some of the rare diseases mentioned in the National Policy For Rare Diseases 2021 list include Wilson’s disease, cystic fibrosis and Pompe disease.
The government’s move on exemption comes amid reports that several Indian families have had to raise money through online fundraising campaigns to receive pricey medicines such as Novartis’ (NOVN.S) $2.1 million gene therapy, Zolgensma, for treating spinal muscular atrophy.
WASHINGTON: The UN agency for Palestinian refugees (UNRWA) says that food distribution in Gaza’s southern…
F.P. Report ISLAMABAD: Prime Minister Muhammad Shehbaz Sharif on Tuesday while expressing satisfaction over the…
F.P. Report KARACHI: Sindh Senior Minister Sindh Sharjeel Inam Memon said Tuesday that the Sindh…
F.P. Report PESHAWAR: As an important initiative to improve health emergency response to road traffic…
F.P. Report ISLAMABAD: The Jamiat Ulema-e-Islam-Fazl (JUI-F) has submitted a draft constitutional amendment to the…
F.P. Report LAHORE: The Lahore High Court (LHC) on Tuesday granted bail to former Punjab…
This website uses cookies.